These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. Harris DJ, Douglas PS. N Engl J Med; 2000 Aug 17; 343(7):475-80. PubMed ID: 10944565 [Abstract] [Full Text] [Related]
3. The female heart is vulnerable to cardiovascular disease: emerging prevention evidence for women must inform emerging prevention strategies for women. Wenger NK. Circ Cardiovasc Qual Outcomes; 2010 Mar 17; 3(2):118-9. PubMed ID: 20233978 [No Abstract] [Full Text] [Related]
4. What can we learn from design faults in the Women's Health Initiative randomized clinical trial? Tan O, Harman SM, Naftolin F. Bull NYU Hosp Jt Dis; 2009 Mar 17; 67(2):226-9. PubMed ID: 19583558 [Abstract] [Full Text] [Related]
6. Heart association issues new guidelines on cardiovascular disease prevention in women. Rollins G. Rep Med Guidel Outcomes Res; 2004 Feb 20; 15(4):1-2, 6-7. PubMed ID: 15000094 [No Abstract] [Full Text] [Related]
7. State of the heart: building science to improve women's cardiovascular health. Rosenfeld AG. Am J Crit Care; 2006 Nov 20; 15(6):556-66; quiz 567. PubMed ID: 17053263 [Abstract] [Full Text] [Related]
9. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials. Ding EL, Powe NR, Manson JE, Sherber NS, Braunstein JB. Arch Intern Med; 2007 May 14; 167(9):905-12. PubMed ID: 17502531 [Abstract] [Full Text] [Related]
10. Cardiovascular disease prevention tailored for women. Engberding N, Wenger NK. Expert Rev Cardiovasc Ther; 2008 Sep 14; 6(8):1123-34. PubMed ID: 18793115 [Abstract] [Full Text] [Related]
15. Do diet, folic acid, and vitamins matter? What did we learn from the Women's Health Initiative, the Women's Health Study, the Women's Antioxidant and Folic Acid Cardiovascular Study, and other clinical trials? Wenger NK. Cardiol Rev; 2007 Dec 14; 15(6):288-90. PubMed ID: 18090063 [Abstract] [Full Text] [Related]
16. [Cardiovascular risk factors and prevention in women: similarities and differences]. Sclavo M. Ital Heart J Suppl; 2001 Feb 14; 2(2):125-41. PubMed ID: 11255880 [Abstract] [Full Text] [Related]
18. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan. Morimoto T, Fukui T, Lee TH, Matsui K. Am J Med; 2004 Oct 01; 117(7):459-68. PubMed ID: 15464702 [Abstract] [Full Text] [Related]
19. Assessment of analysis by gender in the Cochrane reviews as related to treatment of cardiovascular disease. Johnson SM, Karvonen CA, Phelps CL, Nader S, Sanborn BM. J Womens Health (Larchmt); 2003 Jun 01; 12(5):449-57. PubMed ID: 12869292 [Abstract] [Full Text] [Related]